Document is current
Any future updates will be listed below
-
Authors
Gschwend, Anna
Helbling, Arthur
Feldmeyer, Laurence
Mani-Weber, Ulrich
Meincke, Cordula
Heidemeyer, Kristine
Bossart, Simon
Jörg, Lukas
-
Funding
Funding for this research was provided by:
University of Bern
- License Information
-
More Information
Article History
Received: 5 April 2022
Accepted: 15 July 2022
First Online: 23 August 2022
Declarations
:
: L. Jörg has received advisory board fees from Astra Zeneca and speaker fees from GSK. A. Helbling has received advisory board fees from Astra Zeneca and GSK. A. Gschwend has received speaker fees from GSK. L. Feldmeyer, U. Mani-Weber, C. Meincke, K. Heidemeyer and S. Bossart declare that they have no competing interests.
: The study was approved by the local ethics committee (Kantonale Ethikkommission Bern ID 2018-02192). <i>Consent to participate:</i> All patients included gave informed consent for study participation and data publication. <i>Confirmation of unpublished work:</i> All authors approved the content of the manuscript and this submission. All authors listed have contributed sufficiently to the project to be included as authors.
